Tru Singular Health, Inc. — SEC Form D Filing

Tru Singular Health, Inc. filed an SEC Form D on October 30, 2026, reporting $1.00M raised in Biotechnology.

Form D filing details

Filing
SEC Form D
Filing date
October 30, 2026
Amount reported
$1.00M
Round stage
Seed stage based on the $1,000,000 raised via Simple Agreements for Future Equity to fund early technical development.
Industry
Biotechnology
Website
https://www.trusingular.com

What the company does

Securities: Simple Agreements for Future Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Conventional biotech research struggles with high failure rates and inefficient discovery workflows in targeted therapeutic development.

Solution

Tru Singular Health builds novel biotechnology solutions to accelerate precision drug discovery and candidate development.

Why now

Recent breakthroughs in computational biology and functional genomics enable highly targeted therapeutic discovery at a fraction of historical costs.

Source: SEC EDGAR Form D filing